Table 2.
Overview of included studies.
Characteristics | No. of studies | Studies |
---|---|---|
Country | ||
Unites States | 25 | [7, 38, 39, 40, 41, 47, 49, 50, 51, 52, 53, 54, 55, 56, 60, 62, 65, 66, 68, 69, 70, 71, 72, 73, 74] |
United Kingdom | 5 | [25, 45, 58, 75, 76, 77] |
Canada | 4 | [24, 57, 59, 78] |
Brazil | 2 | [43, 63] |
Germany | 1 | [79] |
Australia | 4 | [18, 29, 80, 81] |
Portugal | 1 | [37] |
Jordan | 1 | [82] |
Switzerland | 3 | [27, 46, 83] |
Sweden | 1 | [48] |
Malaysia | 1 | [42] |
Setting | ||
PICU | 9 | [50, 54, 62, 65, 66, 72, 75, 78, 83] |
Inpatient unit | 21 | [7, 18, 27, 29, 40, 41, 43, 46, 47, 48, 51, 55, 56, 57, 58, 59, 69, 73, 74, 76, 77] |
Both | 3 | [24, 68, 70] |
Other/not specifieda | 16 | [25, 37, 38, 39, 42, 45, 49, 52, 53, 60, 63, 71, 79, 80, 81, 82] |
Participants | ||
Parental caregivers | 41 | [7, 18, 24, 27, 29, 37, 38, 39, 40, 42, 43, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 62, 63, 65, 66, 68, 69, 70, 71, 72, 73, 78, 79, 82, 83] |
CMC | 3 | [41, 76, 77] |
Both | 2 | [74, 75] |
Other/not specifieda | 3 | [25, 38, 80] |
Sample size | ||
5–10 | 13 | [37, 40, 43, 45, 48, 51, 58, 62, 63, 65, 72, 76, 77] |
11–24 | 10 | [39, 42, 54, 57, 60, 71, 78, 79, 82, 83] |
25–100 | 16 | [18, 41, 46, 47, 49, 50, 52, 55, 56, 59, 66, 68, 69, 73, 74, 75] |
> 100 | 4 | [24, 27, 29, 70] |
Other/not specifieda | 6 | [7, 25, 38, 53, 80, 81] |
Includes review articles.